IRIS
LIUZZI, Grazia Maria
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 5.624
EU - Europa 1.339
AS - Asia 427
OC - Oceania 4
SA - Sud America 2
Continente sconosciuto - Info sul continente non disponibili 1
Totale 7.397
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 5.615
CN - Cina 403
SE - Svezia 380
UA - Ucraina 242
IT - Italia 185
DE - Germania 166
FI - Finlandia 127
FR - Francia 112
GB - Regno Unito 61
BE - Belgio 22
IE - Irlanda 20
IN - India 14
CA - Canada 8
IR - Iran 8
NL - Olanda 7
RU - Federazione Russa 6
AU - Australia 4
HU - Ungheria 2
PL - Polonia 2
PT - Portogallo 2
AT - Austria 1
BG - Bulgaria 1
BR - Brasile 1
ES - Italia 1
EU - Europa 1
GR - Grecia 1
JP - Giappone 1
KR - Corea 1
MX - Messico 1
PE - Perù 1
SI - Slovenia 1
Totale 7.397
Salva come PNG Salva come JPEG
Città #
Woodbridge 682
Fairfield 604
Chandler 603
Jacksonville 561
Houston 405
Ann Arbor 334
Ashburn 326
Nyköping 317
Wilmington 243
Seattle 239
Cambridge 227
Lawrence 127
Roxbury 126
Nanjing 111
Marseille 97
Beijing 92
Des Moines 79
New York 67
Bari 66
Boardman 66
Inglewood 56
Princeton 39
Shenyang 33
Jiaxing 31
Nanchang 29
Brooklyn 26
Hebei 25
San Diego 25
Brussels 22
Changsha 21
Dublin 20
Spongano 17
Leawood 16
Tianjin 16
Dearborn 15
Auburn Hills 13
Monmouth Junction 12
Falls Church 11
Augusta 9
Norwalk 9
Paris 9
Pune 8
Amsterdam 7
Ardabil 7
Kunming 7
London 7
Los Angeles 7
Washington 7
Zhengzhou 7
Guangzhou 6
Hefei 6
Helsinki 6
Indiana 6
Jinan 6
Rome 6
San Mateo 6
Giovinazzo 5
Scottsdale 5
Adelfia 4
Kilburn 4
Mumbai 4
Ningbo 4
San Francisco 4
Toronto 4
Palermo 3
Siena 3
Taizhou 3
Taranto 3
Edmonton 2
Frankfurt am Main 2
Gothenburg 2
Grafing 2
Lecce 2
Melbourne 2
Miskolc 2
Molfetta 2
Prescot 2
Regensburg 2
Sydney 2
Torino 2
Triggiano 2
Turin 2
Algonquin 1
Andria 1
Athens 1
Bergamo 1
Boydton 1
Brampton 1
Brindisi 1
Cerignola 1
Chiswick 1
Corato 1
Cupertino 1
Fasano 1
Fuzhou 1
Giurdignano 1
Hanover 1
Hounslow 1
Hyderabad 1
Lima 1
Totale 6.017
Salva come PNG Salva come JPEG
Nome #
Inhibitory Effect of Aqueous Extracts from Marine Sponges on the Activity and Expression of Gelatinases A (MMP-2) and B (MMP-9) in Rat Astrocyte Cultures 107
Adhesion molecules and matrix metalloproteinases in Multiple Sclerosis: effects induced by Interferon-beta 105
Cytotoxicity Study on Luminescent Nanocrystals Containing Phospholipid Micelles in Primary Cultures of Rat Astrocytes 101
A thermodynamic and structural study of myelin basic protein in lipid membrane models 98
Biological variations in a long-term ex situ cultivation: a Mediterranean demosponge as model system 97
Native Myelin Proteins and Myelin Assembly in the Central Nervous System 95
Comparative analysis of protein profiles of aqueous extracts from marine sponges and assessment of cytotoxicity on different mammalian cell types 94
Apolipoprotein(a) inhibits lipopolysaccharide-induced IL-6 secretion in human astrocytoma cell line by interfering with lipopolysaccharide signaling 92
In Vitro Downregulation of Matrix Metalloproteinase-9 in Rat Glial Cells by CCR5 Antagonist Maraviroc: Therapeutic Implication for HIV Brain Infection. 91
null 91
null 90
A monoclonal antibody inhibits gelatinase B/MMP-9 by selective binding to part of the catalytic domain and not to the fibronectin or zinc binding domains 90
Cerebrospinal fluid myelin basic protein as predictive marker of demyelination in AIDS dementia complex 90
Structure-Dependent Inhibition of Gelatinases by Dietary Antioxidants in Rat Astrocytes and Sera of Multiple Sclerosis Patients 89
T-cell response to myelin basic protein and lipid-bound myelin basic protein in patients with multiple sclerosis and healthy donors 89
Identification of water-soluble proteases in myelin preparations 87
null 87
Matrix metalloproteinase dysregulation in HIV infection: implications for therapeutic strategies 86
Liver fibrosis in HCV monoinfected and HIV/HCV coinfected patients: Dysregulation of matrix metalloproteinases (MMPs) and their tissue inhibitors TIMPs and effect of HCV protease inhibitors 86
Antibodies specific for the lipid-bound form of myelin basic protein during experimental autoimmune encephalomyelitis 86
Autoimmune Myelofibrosis: report of three cases and review of the literature 85
Different recognition by clostripain of myelin basic protein in the lipid-free and lipid-bound forms 83
Myelin degrading activity in the CSF of HIV-1-infected patients with neurological diseases 83
New Diagnostic and Therapeutic Options for the Treatment of Multiple Sclerosis 82
FAD synthesis and degradation in the nucleus create a local flavin cofactor pool 82
Serum MMP-2 and MMP-9 are elevated in different multiple sclerosis subtypes 80
Crystals of P2 myelin protein in lipid-bound form 79
Antiretroviral Treatment Modulates The Release Of Matrix Metalloproteinases In Rat Astrocyte Cell Cultures 78
Regulation of gelatinases in microglia and astrocyte cell cultures by plant lectins 78
Aquaporin-4-containing astrocytes sustain a temperature- and mercury-insensitive swelling in vitro 77
Heterogeneity of serum gelatinases MMP-2 and MMP-9 isoforms and charge variants. 76
Expression of myelin basic protein (MBP) epitopes in human non-neural cells revealed by two anti-MBP IgM monoclonal antibodies 76
Detection of cerebrospinal fluid antibodies against myelin basic protein in patients with AIDS dementia complex 76
May diet and dietary supplements improve the wellness of multiple sclerosis patients? A molecular approach. 75
BLOOD MMP-9 AND SICAM-1 AS MARKERS OF RIFN-B TREATMENT EFFICACY IN RELAPSING-REMITTING MS 74
In vitro effect of antiretroviral drugs on cultured primary astrocytes: analysis of neurotoxicity and matrix metalloproteinase inhibition 74
Lipoprotein(a) in the cerebrospinal fluid of neurological patients with blood-cerebrospinal fluid barrier dysfunction 72
Antiretroviral therapy inhibits matrix metalloproteinase-9 from blood mononuclear cells of HIV-infected patients 72
INTERFERON-beta INHIBITS THE EXPRESSION OF METALLOPROTEINASES IN RAT GLIAL CELL CULTURES: IMPLICATIONS FOR MULTIPLE SCLEROSIS PATHOGENESIS AND TREATMENT 71
Marine pharmacology: Therapeutic targeting of matrix metalloproteinases in neuroinflammation 71
Purification of bovine P2 myelin protein with bound lipids 70
Neuroprotective effect of resveratrol egainst Manganese-induced Matrix Matalloproteinases-9 and oxidative stress in a “vivo” model of neurotoxicity. 69
Recombinant arabidopsis HSP70 sustains cell survival and metastatic potential of breast cancer cells 69
Antiretroviral treatment modulates the release of matrix metalloproteinases in rat astrocyte cell cultures 68
Laminar order within Langmuir-Blodgett multilayers from phospholipid and myelin basic protein: a neutron reflectivity study 68
Anti-endothelial cell antibodies (AECA) in a patient wiyh Takayasu’s arteritis. In: Pathogenesis and immunotherapy of autoimmune diseases. Final program and abstract book 68
The different forms of PNS myelin P0 protein within and outside lipid rafts 66
Release of myelin basic protein-degrading proteolytic activity from microglia and macrophages after infection with Theiler's murine encephalomyelitis virus: comparison between susceptible and resistant mice 66
Induction of experimental autoimmune encephalomyelitis in rats and immune response to myelin basic protein in lipid-bound form 63
Ruolo delle proteasi nell’induzione e nella patogenesi della sclerosi multipla 62
Inhibition of aquaporin-4 expression in astrocytes by RNAi determines alteration in cell morphology, growth, and water transport and induces changes in ischemia-related genes 61
Dysregulation of MMPs and TIMPs in HCV in monoinfected and HCV/HIV coinfected patients. Positive effect of HCV protease inhibitor treatment. 60
Impact of lead neurotoxicity on gelatinase production in THP-1 cells. effects of antioxidants and therapeutical implication for the treatment of cns diseases 60
Lipoprotein(a) presence in the cerebrospinal fluid of patients with neurologic disorders 60
Intrathecal synthesis of matrix metalloproteinase-9 in patients with multiple sclerosis: implication for pathogenesis 60
Increased Gelatinase B Activity in the CSF of Patients with HIV-Associated Neurological Diseases 58
In vitro effect of antiretroviral drugs on cell toxicity and matrix metalloproteinase-9 inhibition in cultured primary astrocytes. 57
CHANGES OF SERUM ICAM-1 AND MMP-9 INDUCED BY RIFNB-1B TREATMENT IN RELAPSING-REMITTING MS 57
Inhibition of myelin-cleaving proteolytic activities by interferon-beta in rat astrocyte cultures. Comparative analysis between gelatinases and calpain-II. 57
Meccanismi di demielinizzazione in pazienti con neuroAIDS 56
null 56
Coordinated inhibition of Matrix Metalloproteinase-9 and Urokinase Plasminogen activator by immunomodulant therapies in peripheral blood Mononuclear Cells from MS patients 55
Inhibitory Effect of Polyunsaturated Fatty Acids on MMP-9 Release from Microglial Cells-Implications for Complementary Multiple Sclerosis Treatment 55
Intrathecal synthesis of matrix metalloproteinase (MMP)-9 in patients with relapsing-remitting (RR) multiple sclerosis (MS) 54
CEREBROSPINAL FLUID MARKERS FOR THE MONITORING OF AIDS DEMENTIA COMPLEX SEVERITY: USEFULNESS OF ANTI-MYELIN BASIC PROTEIN ANTIBODY DETECTION 54
In vitro downregulation of matrix metalloproteinase-9 in rat astrocytes by CCR5 antagonist maraviroc: potential therapeutical implication for HIV-associated neurological disease. 54
Decreased levels of serum Gelatinase B in MS patients treated with rIFN-beta-1b 54
CNS Myelin Proteins in Lipid-Bound Native Form as Tools for Study, Detection and Treatment of Multiple Sclerosis 52
Detection of serum levels and intrathecal synthesis of matrix metallo proteinase-9 in relapsing-remitting multiple sclerosis 52
Impact of manganese neurotoxicity on gelatinase production in rat primary astrocytes. Effect of resveratrol and therapeutical implications for the treatment of CNS diseases. 52
Aids dementia complex. On the relationship between HIV-1 infection, immune-mediated response and myelin damage in the brain 52
Increased activity of matrix metalloproteinases in the cerebrospinal fluid of patients with HIV-associated neurological diseases 52
Matrix metalloproteinase-9 and tissue inhibitors of matrix metalloproteinase-1 in plasma of patients co-infected with HCV and HIV 51
Matrix metalloproteinases in demyelinating diseases: targets for treatment. 51
Autoimmune bone marrow fibrosis: a distinct clinicopathological entity 51
Determinazione degli Anticorpi Liquorali Anti-MBP per la Diagnosi di Danno Mielinico in Pazienti con AIDS Dementia Complex 49
CHANGES OF SERUM SOLUBLE ICAM-1 AND MATRIX METALLOPROTEINASE-9 DURING INTERFERON BETA-1B TREATMENT IN RR MS 48
Il ruolo delle proteasi nell’induzione e nella patogenesi della Sclerosi Multipla 48
Meccanismo molecolare di “Swelling” in astrociti in coltura 48
Demyelination and cerebral toxoplasmosis in HIV-infected patients 47
Matrix Metalloproteinases in CNS Inflammation. 47
Follow-up of myelin damage in HIV-associated cryptococcal meningitis. First evidence of anti-myelin basic protein antibodies in the cerebrospinal fluid 47
In vitro cell toxicity and Matrix Metalloproteinase-9 inhibition by antiretroviral drugs in cultured primary astrocytes 47
null 47
Plant Lectins Regulate the Release of Matrix Metalloproteases in Rat Glial Cell Cultures 46
Assessment of cell toxicity and matrix metalloproteinase-9 expression by antiretroviral drugs in cultured primary astrocytes. 46
Extracting and purifying R-phycoerythrin from Mediterranean red algae Corallina elongata Ellis & Solander 45
Aumento dell’attività della Gelatinasi B nel liquor di pazienti HIV-positivi con malattie neurologiche del Sistema Nervoso Centrale 45
Regulation of gelatinases in microglia and astrocyte cell cultures by plant lectins 45
Detection of MMP-9 sialylated isotypes in sera of patients with relapsing/remitting multiple sclerosis 44
Interferon-beta Treatment Inhibits Calpain Expression In Rat Astrocytes. Implications For Ms Pathogenesis And Treatment. 42
Dynamic changes of MMP-9 plasma levels correlate with JCV reactivation and immune activation in natalizumab-treated multiple sclerosis patients 42
Evaluation of Cell Toxicity and Matrix Metalloproteinase-9 Inhibition by combination of Antiretroviral Drugs in Cultured Primary Astrocytes. Implication for the treatment of neuroAIDS. 41
The effects of dietary antioxidants on gelatinase activity in cultured rat astrocytes. implications for the complementary treatment of multiple sclerosis. 40
ADHESION MOLECULES AND MATRIX METALLOPROTEINASES IN MS: EFFECTS INDUCED BY INTERFERON BETA 40
Plant lectins regulate the release of matrix metallo proteinases in rat glial cell cultures 39
Plant lectins regulate the release of gelatinases in rat glial cell cultures?? 39
Regolazione del rilascio di gelatinasi da parte di cellule gliali trattate con lectine vegetali 37
FAD synthase deficiency: a severe mitochondrial myopathy searching for novel therapeutic strategies 37
MMP-9 activity in serum samples from MS patients at different disease stages and during rIFN-beta-1b treatment 36
Totale 6.537
Salva come PNG Salva come JPEG
Categoria #
all - tutte 26.114
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 26.114
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2018/2019468 0 0 0 0 0 0 0 0 0 0 221 247
2019/20201.721 338 122 46 143 179 89 189 127 208 100 151 29
2020/20211.066 117 43 116 30 131 36 103 67 112 154 121 36
2021/2022805 24 116 6 24 33 51 32 47 57 55 158 202
2022/20231.687 197 138 109 170 216 214 13 188 347 43 25 27
2023/2024483 44 97 23 120 46 118 7 6 6 14 2 0
Totale 7.513